Merit Medical Removes 16F Dual-Valved Splittable Sheath Introducer
Design Defect May Lead to Hemorrhage, Embolization, and Loss of Vascular Access
The U.S. Food and Drug Administration (FDA) has identified a Class I recall involving Merit Medical’s 16F Dual-Valved Splittable Sheath Introducer, a component used in multiple dialysis catheter systems. A Class I recall is the FDA’s most serious classification and indicates that continued use of the device may cause serious injury or death.
Affected Products
The recalled sheath introducer, used in vascular access procedures for hemodialysis patients is included in the following systems:
Centros & CentrosFLO Hemodialysis Catheters
ProGuide Chronic Dialysis Catheters
DuraMax Chronic Hemodialysis Catheter
BioFlo DuraMax Catheter
16F Dual-Valved Splittable Sheath Introducer (bulk, non-sterile)
Reason for Recall
Merit Medical initiated the recall due to a design defect in which the sheath introducer may fail to split as intended during catheter placement. This failure can compromise the procedure and create significant clinical risk.
Potential Risks
Failure of the sheath introducer may result in hemorrhage, retained foreign body, procedure delay, embolization or thrombosis, impaired catheter function, or loss of vessel for future vascular access. These complications are particularly serious in dialysis patients, where vascular access is critical and often limited.
Reported Events
As of February 23, Merit Medical has reported two serious injuries and no deaths.
Device Use
The 16F Dual-Valved Splittable Sheath Introducer, which is packaged within dialysis catheter kits, is used to introduce the catheter into the vascular system. It is designed to split and be removed after catheter placement. Failure of the device to split properly directly impacts procedural safety and outcomes.
What Healthcare Providers Should Do
Merit Medical has instructed customers to immediately stop using the 16F Dual-Valved Splittable Sheath Introducer, apply recall notification stickers to affected kits, and destroy the sheath introducer at the point of use. Customers may continue using other components in the kits, if appropriate.
MDP Analysis
Design Failure in a Critical Procedural Component
This recall highlights a key regulatory and quality concern, that the failure of a seemingly simple mechanical function can have high clinical consequences. The sheath introducer plays a critical role in vascular access procedures, and its failure introduces multiple layers of risk, including procedural complications, patient safety impact, and long-term treatment limitations.
Regulatory and Quality Considerations
This event raises important questions regarding design validation for device functionality under clinical conditions, human factors and usability in high-risk procedures, verification of mechanical performance under real-world use scenarios, and supplier and component-level risk management.
For manufacturers, this underscores the importance of robust design controls, comprehensive verification and validation, and risk-based evaluation of component failure modes.
Broader Industry Insight
In complex medical systems, component-level failures can drive system-level risk. Even when the primary device (e.g., catheter) is functioning as intended, failure of a supporting component can compromise the entire procedure, increase patient risk, and trigger regulatory action.
Merit Medical Contact Information
Healthcare providers with questions or adverse event reports should contact Merit Medical Customer Service by phone at 1-800-356-3748, or email at response@merit.com.
MDP Perspective
This recall illustrates a fundamental principle. Device safety depends on the reliability of every component, not just the primary system. For manufacturers, it reinforces the need for integrated risk management, end-to-end system validation, and vigilant postmarket surveillance.
Contact Us
Do you need support evaluating design controls, risk management, or recall response strategies? MDP provides expert guidance in quality systems, regulatory compliance, and postmarket risk mitigation. Contact us today.
Links
Merit Medical recall page
Read the FDA’s announcement here.
Download the Merit Medical Recall Letter
Download the List of Recalled Product Lot Numbers
Intersurgical 22mm Smoothbore Breathing Tubes and Systems
FDA Issues Early Alert for Intersurgical Breathing Systems Over Potential Ventilation Failure. Manufacturing defect may cause breathing tube connectors to separate during use, potentially interrupting ventilation and exposing patients to serious injury or death.The...
FDA Early Alert: Teleflex/Arrow Guidewire
Affected guidewires and catheter products may release hydrophilic polymer particles into the bloodstream, potentially causing serious injury or death. No serious injuries or deaths have been reported.The U.S. Food and Drug Administration (FDA) has issued an Early...
FDA Investigates Cancer Risk with Zolgensma Gene Therapy
Postmarketing reports identify cases of tumor formation linked to gene therapy vector integration, prompting FDA to evaluate potential regulatory action.The U.S. Food and Drug Administration (FDA) is investigating a serious potential cancer risk associated with...
Eugia Vancomycin Recall: Glass Particle Contamination
FDA announces voluntary recall of a single lot of vancomycin hydrochloride for injection because of potentially dangerous particulate contamination.Eugia US LLC, formerly Auro Medics Pharma LLC, has initiated a voluntary nationwide recall of one lot of Vancomycin...
FDA Requires New GLP-1 Drug Warning for Vision Loss Risk
Agency cites potential increased risk of rare optic nerve condition following review of clinical trials and postmarket safety dataThe U.S. Food and Drug Administration (FDA) is requiring manufacturers of all glucagon-like peptide-1 receptor agonist (GLP-1 RA)...
Class 1 Recall for HemosIL AcuStar HIT Antibody Test
HemosIL AcuStar HIT-IgG(PF4-H). Source: fda.govPerformance problems could produce false-negative results, potentially delaying diagnosis of a dangerous reaction to heparin.The U.S. Food and Drug Administration (FDA) has identified a recall of certain lots of the...

